Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
Article in Cancer Letters (February 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in Cancer Letters (February 2024)
Article in The Innovation Medicine (January 2024)
Article in The Innovation Medicine (January 2024)